🇺🇸 FDA
Patent

US 8389478

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

granted A61PA61P25/28A61P43/00

Quick answer

US patent 8389478 (Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory) held by The Regents of the University of California expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P25/28, A61P43/00